| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |